Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$11.48 - $15.86 $8,116 - $11,213
707 Added 3.04%
23,962 $312,000
Q4 2023

Feb 14, 2024

SELL
$6.03 - $12.88 $495,539 - $1.06 Million
-82,179 Reduced 77.94%
23,255 $296,000
Q3 2023

Nov 14, 2023

SELL
$12.16 - $24.87 $879,459 - $1.8 Million
-72,324 Reduced 40.69%
105,434 $1.38 Million
Q2 2023

Aug 14, 2023

BUY
$23.91 - $27.81 $936,172 - $1.09 Million
39,154 Added 28.25%
177,758 $4.55 Million
Q1 2023

May 15, 2023

BUY
$20.23 - $26.22 $875,878 - $1.14 Million
43,296 Added 45.43%
138,604 $3.49 Million
Q4 2022

Feb 14, 2023

BUY
$20.54 - $24.67 $1.96 Million - $2.35 Million
95,308 New
95,308 $2.19 Million

Others Institutions Holding TMCI

About TREACE MEDICAL CONCEPTS, INC.


  • Ticker TMCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 55,403,300
  • Market Cap $423M
  • Description
  • Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...
More about TMCI
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.